Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|January 8, 2014
Erythema multiforme secondary to dimenhydrinate in a patient with previous similar reactions to pamabromDoreen Su-Yin Tan, Grant E Sklar
European Cardiology|July 21, 2020
Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future HoldsGrace Shu-Wen Chang, Doreen Su-Yin Tan
Cardiovascular Drugs and Therapy|May 14, 2022
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from SingaporeXin Qin Soh, Doreen Su-Yin Tan, Eric Chun Yong Chan
The Pharmacogenomics Journal|January 19, 2021
Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in SingaporeJi Heon Kim, Doreen Su-Yin Tan, Mark Yan Yee Chan
Seminars in Thrombosis and Hemostasis|July 28, 2025
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?Bingwen Eugene Fan, Jia Hui Melissa Tan, Doreen Su-Yin Tan
Future Cardiology|June 12, 2020
Perspective on CYP2C19 genotyping test among patients with acute coronary syndrome - a qualitative studyWan Yu Png, Xin Yi Wong, Yu Heng Kwan, et al.
Clinical Drug Investigation|September 22, 2020
Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function MutationsKaavya Narasimhalu, Yoong Kwei Ang, Doreen Su Yin Tan, et al.
Singapore Medical Journal|August 6, 2015
Prevalence of dysglycaemic events among inpatients with diabetes mellitus: a Singaporean perspectiveKheng Yong Ong, Yu Heng Kwan, Hooi Ching Tay, et al.
Journal of Human Hypertension|October 27, 2022
The clinical impact of anti-hypertensive treatment drug-gene pairs in the asian population: a systematic review of publications in the past decadeSarah Wai Yee Tang, Aaron Shengting Mai, Nicholas W S Chew, et al.
European Heart Journal|December 28, 2018
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trialsKang-Ling Wang, Renato D Lopes, Manesh R Patel, et al.
Pageof 3